Positive and negative allosteric modulation of metabotropic glutamate receptors: emerging therapeutic potential

被引:109
作者
Kew, JNC [1 ]
机构
[1] GlaxoSmithKline, Psychiat Ctr Excellence Drug Discovery, Harlow CM19 5AW, Essex, England
关键词
G-protein-coupled receptor; metabotropic glutamate receptor; positive allosteric modulator; negative allosteric modulator;
D O I
10.1016/j.pharmthera.2004.08.010
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Metabotropic glutamate receptors (mGluRs) modulate neuronal activity in the central and peripheral nervous systems, and since their discovery have attracted considerable attention as putative therapeutic targets for a range of neurological and psychiatric disorders. A number of competitive agonists and antagonists acting at the N-terminal glutamate binding site have been identified, the majority of which are conformationally constrained or substituted amino acid analogues. These ligands have greatly facilitated investigation of the physiological and pathological roles of the receptor family. However, their utility and therapeutic potential has been restricted by relatively poor bioavailability and central nervous system (CNS) penetration, as well as limited chemical tractability and, generally, a lack of selectivity for individual mGluRs. Recently, a number of non-competitive mGluR ligands have been identified which bind within the receptor transmembrane heptahelical domain. These include both positive and negative allosteric modulators. Positive allosteric modulators do not exhibit intrinsic agonism but facilitate agonist-mediated receptor activity. Negative allosteric modulators include both non-competitive antagonists and inverse agonists. Allosteric modulation offers the potential for improved selectivity, particularly for individual receptors within the mGluR family, and enhanced chemical tractability relative to competitive agonists/antagonists. In addition, positive allosteric modulation provides a distinct, and perhaps superior, profile to receptor agonism, offering the potential for facilitation of physiologically appropriate receptor activation with reduced liability for receptor desensitisation and/or tolerance. Thus, the emerging field of positive and negative allosteric modulation of the mGluR family offers considerable promise for the development of novel therapeutics. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:233 / 244
页数:12
相关论文
共 68 条
  • [1] A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates
    Annoura, H
    Fukunaga, A
    Uesugi, M
    Tatsuoka, T
    Horikawa, Y
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (07) : 763 - 766
  • [2] Metabotropic glutamate receptors: electrophysiological properties and role in plasticity
    Anwyl, R
    [J]. BRAIN RESEARCH REVIEWS, 1999, 29 (01) : 83 - 120
  • [3] Membrane topology of a metabotropic glutamate receptor
    Bhave, G
    Nadin, BM
    Brasier, DJ
    Glauner, KS
    Shah, RD
    Heinemann, SF
    Karim, F
    Gereau, RW
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (32) : 30294 - 30301
  • [4] Peripheral group I metabotropic glutamate receptors modulate nociception in mice
    Bhave, G
    Karim, F
    Carlton, SM
    Gereau, RW
    [J]. NATURE NEUROSCIENCE, 2001, 4 (04) : 417 - 423
  • [5] PHENYLGLYCINE DERIVATIVES DISCRIMINATE BETWEEN MGLUR1-MEDIATED AND MGLUR5-MEDIATED RESPONSES
    BRABET, I
    MARY, S
    BOCKAERT, J
    PIN, JP
    [J]. NEUROPHARMACOLOGY, 1995, 34 (08) : 895 - 903
  • [6] BAY36-7620:: A potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.
    Carroll, FY
    Stolle, A
    Beart, PM
    Voerste, A
    Brabet, I
    Mauler, F
    Joly, C
    Antonicek, H
    Bockaert, J
    Müller, T
    Pin, JP
    Prézau, L
    [J]. MOLECULAR PHARMACOLOGY, 2001, 59 (05) : 965 - 973
  • [7] Regulation of neurotransmitter release by metabotropic glutamate receptors
    Cartmell, J
    Schoepp, DD
    [J]. JOURNAL OF NEUROCHEMISTRY, 2000, 75 (03) : 889 - 907
  • [8] Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia
    Chavez-Noriega, Laura E.
    Schaffhauser, Herve
    Campbell, Una C.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (03) : 261 - 281
  • [9] Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
    Chiamulera, C
    Epping-Jordan, MP
    Zocchi, A
    Marcon, C
    Cottiny, C
    Tacconi, S
    Corsi, M
    Orzi, F
    Conquet, F
    [J]. NATURE NEUROSCIENCE, 2001, 4 (09) : 873 - 874
  • [10] L-Amino acid sensing by the extracellular Ca2+-sensing receptor
    Conigrave, AD
    Quinn, SJ
    Brown, EM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (09) : 4814 - 4819